Compounds > 1-(4-carboxyphenyl)-3,3-dimethyltriazene
Page last updated: 2024-08-22

1-(4-carboxyphenyl)-3,3-dimethyltriazene and T-Cell Lymphoma

1-(4-carboxyphenyl)-3,3-dimethyltriazene has been researched along with T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccù, E; Ebert, C; Lassiani, L; Nisi, C; Sava, G; Varnavas, A; Zorzet, S1

Other Studies

1 other study(ies) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and T-Cell Lymphoma

ArticleYear
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK.
    Die Pharmazie, 1990, Volume: 45, Issue:10

    Topics: Animals; Antineoplastic Agents; Carcinoma; Drug Stability; Kinetics; Lung Neoplasms; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Solubility; Triazenes; Tumor Cells, Cultured

1990